TVM Capital Healthcare Invests USD35m in Saudi Arabia’s Boston Oncology Arabia

Source(s): TVM Capital Healthcare

TVM Capital Healthcare invested USD35m in Boston Oncology Arabia, a Saudi Arabia-based bio-generic drugs manufacturer.